Your browser doesn't support javascript.
loading
Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels.
Semerano, L; Biton, J; Delavallée, L; Duvallet, E; Assier, E; Bessis, N; Bernier, E; Dhellin, O; Grouard-Vogel, G; Boissier, M-C.
Affiliation
  • Semerano L; Université Paris-13 Sorbonne Paris Cité, EA4222, Paris, France. luca.semerano@avc.aphp.fr
Clin Exp Immunol ; 172(1): 54-62, 2013 Apr.
Article in En | MEDLINE | ID: mdl-23480185

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Cartilage, Articular / Immunotherapy, Active / Immunization, Passive / Tumor Necrosis Factor-alpha / Antirheumatic Agents / Antibodies Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Exp Immunol Year: 2013 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Cartilage, Articular / Immunotherapy, Active / Immunization, Passive / Tumor Necrosis Factor-alpha / Antirheumatic Agents / Antibodies Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Exp Immunol Year: 2013 Type: Article Affiliation country: France